A PHASE III TWO-ARM RANDOMIZED STUDY COMPARING ANTIANDROGEN WITHDRAWAL ALONE VERSUS ANTIANDROGEN WITHDRAWAL COMBINED WITH KETOCONAZOLE AND HYDROCORTISON IN PATIENTS WITH ADVANCED PROSTAGE CANCER.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antiandrogens; Hydrocortisone; Ketoconazole
- Indications Prostate cancer
- Focus Therapeutic Use
- 28 Jun 2016 Biomarkers information updated
- 01 Sep 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 27 Sep 2005 New trial record.